Nichola (Nick) Eliovits
Chief Financial Officer & Co-Founder
Nick leads finance and business development activities at DermBiont.
His passion for the microbiome and dermatology originates from personal experiences with clostridium difficile (c-diff) and certain skin conditions respectively.
As Managing Partner at Olive Tree Capital, Nick’s investment expertise is industry-agnostic and spans across asset classes with a focus on technology and biotechnology. He led his first technology startup company through acquisition and has successfully seeded and structured multiple companies across various industries.
Nick graduated from Boston University’s Questrom School of Business and started his career in commodities markets at CPM Group in New York.